Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Unicycive Therapeutics, Inc. (UNCY) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-37.82M |
|
-- |
|
-- |
|
$32.12M |
|
$-32.12M |
|
$-4.61M |
|
$-36.73M |
|
$-36.73M |
|
$-36.73M |
|
$-36.73M |
|
$-36.73M |
|
$-36.73M |
|
$-32.12M |
|
$-31.69M |
|
6.70M |
|
6.70M |
|
$-5.60 |
|
$-5.60 |
|
| Balance Sheet Financials | |
$30.95M |
|
$0.07M |
|
$0.72M |
|
$31.67M |
|
$24.12M |
|
-- |
|
$0.12M |
|
$24.24M |
|
$7.43M |
|
$7.43M |
|
$7.43M |
|
11.38M |
|
| Cash Flow Statement Financials | |
$-28.57M |
|
$-0.07M |
|
$45.09M |
|
$9.70M |
|
$26.14M |
|
$16.44M |
|
$2.35M |
|
$-1.09M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.28 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-28.65M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-494.27% |
|
-494.27% |
|
-115.98% |
|
-494.27% |
|
$0.65 |
|
$-4.28 |
|
$-4.27 |
|